Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03843359
Title Phase 1 First Time in Humans (FTIH), Open Label Study of GSK3745417 Administered to Subjects With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site Melbourne 3000 Australia Details
GSK Investigational Site Toronto M5G 1Z9 Canada Details
GSK Investigational Site Bordeaux 33076 France Details
GSK Investigational Site Villejuif cedex 94805 France Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Tokyo 135-8550 Japan Details
GSK Investigational Site Seoul 03080 Korea, Republic of Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Amsterdam 1081 HV Netherlands Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field